Dihydromyricetin regulates intestinal epithelial barrier function of type 2 diabetes mellitus mice through SIRT3

Jing YUE; Jie ZHOU; jinjin JING; Niu DONG; Minghua LIU; Long YI; Mantian MI

doi:10.16016/j.2097-0927.202209074

您当前的位置：

首页 >

文章列表页 >

Dihydromyricetin regulates intestinal epithelial barrier function of type 2 diabetes mellitus mice through SIRT3

Basic Medicine | 更新时间：2026-01-09

- Dihydromyricetin regulates intestinal epithelial barrier function of type 2 diabetes mellitus mice through SIRT3
- Journal of Army Medical University Vol. 45, Issue 3, Pages: 192-201(2023)
- 作者机构：
  
  400038 重庆，陆军军医大学(第三军医大学)军事预防医学系营养与食品安全研究中心，重庆市医学营养研究中心，重庆市营养与食品安全重点实验室
- 作者简介：
- 基金信息：
  
  the General Program of National Natural Science Foundation of China(81973039)
- DOI：10.16016/j.2097-0927.202209074
  CLC： R285.5;R333.3;R587.1
- Received：08 September 2022，
  
  Revised：2022-11-08，
  
  Published：15 February 2023
- 稿件说明：
移动端阅览
Jing YUE, Jie ZHOU, jinjin JING, et al. Dihydromyricetin regulates intestinal epithelial barrier function of type 2 diabetes mellitus mice through SIRT3[J]. Journal of Army Medical University, 2023, 45(3): 192-201.
DOI：

Jing YUE, Jie ZHOU, jinjin JING, et al. Dihydromyricetin regulates intestinal epithelial barrier function of type 2 diabetes mellitus mice through SIRT3[J]. Journal of Army Medical University, 2023, 45(3): 192-201. DOI： 10.16016/j.2097-0927.202209074.

摘要

目的

研究二氢杨梅素(dihydromyricetin，DHM)对高脂饮食(high-fat diet，HFD)诱导2型糖尿病小鼠肠上皮屏障功能的作用，并揭示SIRT3在介导DHM改善肠上皮屏障中的作用机制。

方法

选用7周龄的SPF级雄性野生型(WT)小鼠18只和SIRT3敲除(SIRT3 KO)小鼠30只，分别按随机数字表法分为对照组(NC)、高脂组(HFD)、高脂加二氢杨梅素组(HFD+DHM)，定期监测动物体质量、摄食量。干预12周，检测小鼠肠道通透性。小鼠处死后，检测血清生化指标和LPS水平及肠道组织病理学。利用分离的小鼠小肠上皮细胞和Caco-2细胞系，通过Western blot检测紧密连接蛋白(ZO-1、Occludin)和qRT-PCR检测炎症因子(TNF-α、IL-1β、IL-6)表达。进一步利用慢病毒(LV-SIRT3)感染Caco-2细胞敲降SIRT3表达，DHM和LPS干预后检测相关炎症因子和紧密连接蛋白表达。

结果

HFD诱导WT和SIRT3 KO小鼠体质量明显增加、糖脂代谢异常、肠道通透性增加、肠上皮结构改变(小肠隐窝深度和上皮绒毛长度减少)、肠上皮细胞紧密连接蛋白表达降低和炎症因子表达增加，且与WT小鼠相比，HFD诱导的SIRT3 KO小鼠相关指标改变具有统计学意义(

0.05)。DHM干预后WT小鼠上述检测指标改善具有统计学意义(

0.05)，但DHM的作用在SIRT3 KO小鼠中不明显，差异无统计学意义(

0.05)。体外实验发现，在LV-SIRT3感染的Caco-2细胞中，DHM对LPS诱导的炎症因子表达增加和紧密连接蛋白表达降低作用不明显，且差异无统计学意义(

0.05)。

结论

SIRT3在DHM增加小肠上皮紧密连接蛋白表达、降低炎症因子表达、维持肠上皮屏障完整性和减少通透性、改善糖脂代谢和延缓T2DM发生中发挥重要作用。

Abstract

Objective

To investigate the effect of dihydromyricetin (DHM) on high-fat diet (HFD)-induced intestinal epithelial barrier function in mouse model of type 2 diabetes mellitus (T2DM)

and to reveal the mechanism involved with SIRT3 in mediating DHM in the process.

Methods

Eighteen 7-week-old SPF male wild-type (WT) mice and 30 SIRT3 KO mice were randomly divided into the control group (NC)

HFD group and HFD+DHM group

respectively. The intervention time was 12 weeks. The body weight and food intake of the animals were monitored regularly. At week 12 of intervention

intestinal permeability were tested. After the mice were sacrificed

serum biochemical indexes and LPS levels as well as the intestinal histopathology were detected and observed. The expression of tight junction proteins (ZO-1

Occludin) and inflammatory factors (TNF-α

IL-1β and IL-6) in the isolated small intestinal epithelial cells and Caco-2 cells were detected by qRT-PCR and Western blotting. Then the Caco-2 cells were further infected with lentivirus (LV-SIRT3) to knock down the SIRT3 expression

and the expression levels of above molecules were detected after DHM and LPS treatment.

Results

In the WT and SIRT3 KO mice

HFD induced a significant increased body weight

abnormal glucose level and lipid metabolism

increased intestinal permeability and obvious changes in intestinal epithelial structure (reduced small intestinal epithelium crypt depth and villi length)

as well as decreased levels of tight junction proteins and elevated levels of inflammatory factors. Furthermore

the alterations induced by HFD in SIRT3 KO mice were more significant than those in WT mice (

0.05). The administration of DHM notably ameliorated the associated changes induced by HFD in the WT mice (

0.05) instead of the SIRT3 KO mice (

0.05). In the LV-SIRT3-infected Caco-2 cells

DHM failed to inhibit LPS-induced enhanced expression of the inflammatory cytokines and decreased expression of the tight junction proteins (

0.05).

Conclusion

SIRT3 plays an important role in DHM-induced increased expression of small intestinal epithelial tight junction proteins

reduced expression of the inflammatory factors

maintenance of the intestinal epithelial barrier integrity and permeability and improvement of glycolipid metabolism

and thus is beneficial to delay the development of T2DM.

关键词

Keywords

references

中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2017年版)[J]. 中国实用内科杂志, 2018, 38(4): 292-344.

Diabetes Branch of Chinese Medical Association. Guidelines for the prevention and control of type 2 diabetes in China(2017 Edition)[J]. Chin J Pract Intern Med, 2018, 38(4): 292-344.

THAISS C A, LEVY M, GROSHEVA I, et al . Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection[J ] . Science, 2018, 359(6382): 1376-1383. DOI:10.1126/science.aar3318.

RAN L, WANG X L, LANG H D, et al . Ampelopsis grossedentata supplementation effectively ameliorates the glycemic control in patients with type 2 diabetes mellitus[J ] . Eur J Clin Nutr, 2019, 73(5): 776-782. DOI:10.1038/s41430-018-0282-z.

PASINI E, CORSETTI G, ASSANELLI D, et al . Effects of chronic exercise on gut microbiota and intestinal barrier in human with type 2 diabetes[J ] . Minerva Med, 2019, 110(1): 3-11. DOI:10.23736/s0026-4806.18.05589-1.

GHOSH S S, WANG J, YANNIE P J, et al . Intestinal barrier dysfunction, LPS translocation, and disease development[J ] . J Endocr Soc, 2020, 4(2): bvz039. DOI:10.1210/jendso/bvz039.

CAO S, ZHANG Q, WANG C, et al . LPS challenge increased intestinal permeability, disrupted mitochondrial function and triggered mitophagy of piglets[J ] . Innate Immun, 2018, 24(4): 221-230. DOI:10.1177/1753425918769372.

ROHM T V, MEIER D T, OLEFSKY J M, et al . Inflammation in obesity, diabetes, and related disorders[J ] . Immunity, 2022, 55(1): 31-55. DOI:10.1016/j.immuni.2021.12.013.

MARTIN A, DEVKOTA S. Hold the door: role of the gut barrier in diabetes[J]. Cell Metab, 2018, 27(5): 949-951. DOI:10.1016/j.cmet.2018.04.017.

VAN HUL M, GEURT S L, PLOVIER H, et al . Reduced obesity, diabetes, and steatosis upon cinnamon and grape pomace are associated with changes in gut microbiota and markers of gut barrier[J ] . Am J Physiol Endocrinol Metab, 2018, 314(4): E334-E352. DOI:10.1152/ajpendo.00107.2017.

ROHR M W, NARASIMHULU C A, RUDESKI-ROHR T A, et al . Negative effects of a high-fat diet on intestinal permeability: a review[J ] . Adv Nutr, 2020, 11(1): 77-91. DOI:10.1093/advances/nmz061.

ZHOU J, HOU P, YAO Y, et al . Dihydromyricetin improves high-fat diet-induced hyperglycemia through ILC3 activation via a SIRT3-dependent mechanism[J ] . Mol Nutr Food Res, 2022, 66(16): e2101093. DOI:10.1002/mnfr.202101093..

CHEN M, HUI S, LANG H, et al . SIRT3 deficiency promotes high-fat diet-induced nonalcoholic fatty liver disease in correlation with impaired intestinal permeability through gut microbial dysbiosis[J ] . Mol Nutr Food Res, 2019, 63(4): e1800612. DOI:10.1002/mnfr.201800612.

LI H L, LI Q S,LIU Z W, et al . The versatile effects of dihydromyricetin in health[J ] . Evid Based Complement Alternat Med, 2017, 2017: 1053617. DOI:10.1155/2017/1053617.

LE L, JIANG B P, WAN W T, et al . Metabolomics reveals the protective of dihydromyricetin on glucose homeostasis by enhancing insulin sensitivity[J ] . Sci Rep, 2016, 6: 36184. DOI:10.1038/srep36184.

CAMPBELL C F. Isolation and culture of mouse intestinal cells[J]. Methods Mol Biol, 2010, 633: 197-206. DOI: 10.1007/978-1-59745-019-5_14.

LIU L, WAN J, LANG H D, et al . Dihydromyricetin delays the onset of hyperglycemia and ameliorates insulin resistance without excessive weight gain in Zucker diabetic fatty rats[J ] . Mol Cell Endocrinol, 2017, 439: 105-115. DOI:10.1016/j.mce.2016.10.028.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Dihydromyricetin ameliorates vascular endothelial damage by inhibiting NLRP3 inflammasome activity through Sirtuin 3

Role and mechanism of SIRT3 in oxidative stress and mitochondrial biogenesis in alveolar type II cells

Screening and validation of key molecular targets for dihydromyricetin in ameliorating diabetic nephropathy

Predictive value of TyG-BMI, AIP, and postprandial glucose excursion for sarcopenia in patients with type 2 diabetes mellitus

Renal protective effect of equol on type 2 diabetic rats

Related Author

Minghua LIU

Hui SHEN

Xiaolan WANG

Xi ZHOU

Ting ZHANG

ZHOU Jun

LIU Yaojun

LIU Jing

Related Institution

Department of Nutrition and Food Hygiene, Chongqing Key Laboratory of Nutrition and Food Safety, Chongqing Medical Nutrition Research Center, Faculty of Military Preventive Medicine, Army Medical University (Third Military Medical University)

Department of Human Anatomy， Anhui Medical University

Laboratory of Stem Cell and Tissue Engineering， Chongqing Medical University

Department of Geriatrics and Special Service Medicine， First Affiliated Hospital（Southwest Hospital）， Army Medical University （Third Military Medical University）

Institute of Field Surgery， Daping Hospital， Army Medical University

⁰